Skip to main content
Equibles
OM logo

OM · Outset Medical, Inc. · Documents

Track OM — free

Use OM with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research OM.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$4.46 +0.23 (+5.32%) Play latest call Q3 2026 earnings call transcript
Rebalance outlook locked
Market Cap
$79.83M
Shares
18.87M
Volume · Nov 9 46.93K Avg daily vol (3M) 149.78K

The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →

Annual report FY2025 Revenue $119.48M up 5.1% 10-K filed Feb 13, 2026 Quarterly report New FY2026 Q3 Revenue $33.6M up 14.2% 10-Q filed Nov 4, 2026 Latest results New Revenue rises 14%, 2026 guidance reiterated 8-K filed Nov 4, 2026 Earnings call New Q3 2026 earnings call Held Nov 4, 2026
2026
Nov 4
Earnings call
Revenue grew 14% with 2026 guidance reiterated

Outset Medical reported third-quarter revenue of $33.6 million, up 14% year-over-year, and reiterated 2026 revenue guidance of $125 million to $130 million. Non-GAAP gross margin reached 40.8%.

4 source passages
Welcome to Outset Medical's third quarter 2026 earnings call. Revenue of $33.6 million was up 14% year-over-year and up 6% sequentially. Third quarter non-GAAP gross margin was 40.8%, up approximately 100 basis points compared to last year We are reiterating full-year revenue guidance of $125 million to $130 million. Open the document at this passage
Nov 4
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3 AI summary on its way
Revenue $33.6M ▲ 14.2% Net loss $14.69M Diluted EPS -$0.78
Nov 4
Current report 8-K
Revenue rises 14%, 2026 guidance reiterated

Outset Medical reported third-quarter revenue of $33.6 million, up 14%, gross margin of 40.7% and net loss of $14.7 million. It reiterated 2026 revenue guidance of $125 million to $130 million.

Financial results
5 source passages
Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering a first-of-its-kind technology to improve clinical outcomes in dialysis with less cost and complexity, today reported financial results for the third quarter ended September 30, 2026. Net revenue totaled $33.6 million, an increase of 14% compared to the prior-year period and an increase of 6% sequentially. Gross margin expanded to 40.7%, an increase of 130 basis points compared to the prior-year period. Net loss was $14.7 million compared to net loss of $17.8 million in the third quarter of 2025. Outset reiterated its 2026 revenue guidance of $125 million to $130 million and continues to expect non-GAAP gross margin to be in the low-40% to mid-40% range for the full year. Open the document at this passage
Aug 6
Quarterly report 10-Q FY2026 Q2, ended Jun 30
Quarterly report for FY2026 Q2 AI summary on its way
Revenue $31.64M ▲ 0.7% Net loss $17.98M Diluted EPS -$0.97
May 7
Quarterly report 10-Q FY2026 Q1, ended Mar 31
Quarterly report for FY2026 Q1 AI summary on its way
Revenue $27.86M ▼ 6.3% Net loss $18.98M Diluted EPS -$1.03
Apr 24
Proxy statement DEF 14A Meeting Jun 4, 2026
Proxy statement AI summary on its way
Feb 13
Annual report 10-K FY2025, ended Dec 31
Annual report for FY2025 AI summary on its way
Revenue $119.48M ▲ 5.1% Net loss $81.65M Diluted EPS -$5.37
Jan 27
Current report 8-K
Other events AI summary on its way
2025
Feb 28
Annual report 10-K FY2024, ended Dec 31
Annual report for FY2024
Revenue $113.69M ▼ 12.8% Net loss $127.98M Diluted EPS -$2.46
2024
Showing 1–50 of 140 documents
Key facts CIK 1484612 CUSIP 690145206 13F (30d) 37 filings 25 filers Visit website Investor relations